Skip to main content
Figure 1 | Medical Gas Research

Figure 1

From: Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies

Figure 1

Changes in the levels of the serum oxidative stress marker MDA-LDL (malondialdehyde-modified LDL). Compared to pretreatment levels, the level of serum MDA-LDL 7 d after admission decreased, but did not differ significantly from that of pretreatment levels in all patients (a) and GI patients (b), respectively (85.4 ± 33.5 vs. 82.6 ±31.5, 86.8 ± 34.7 vs. 86.3 ±33.1). By contrast, in comparison with pretreatment levels, GII patients (c) showed a significant decrease in the MDA-LDL level 7 d after admission (82.1 ± 30.2 vs. 73.2 ± 24.6, *P = 0.0111). Values are expressed as mean ± SD.

Back to article page

Medical Gas Research

ISSN: 2045-9912

Contact us